Pyruvate kinase M2 (PKM2), a key glycolysis rate-limiting enzyme, is overexpressed in HCC and is a prognosis marker for poor survival; its knockdown inhibits proliferation and metastasis of HCC cells (Li et al., 2020). The gene discussed is PKM; the disease is hepatocellular carcinoma.